Pérez-Elias MJ - Search Results

1

Lopinavir-ritonavir monotherapy versus lopinavir-ritonavir and 2 nucleosides for maintenance therapy of HIV: 96-week analysis.

Arribas JR, Delgado R, Arranz A, Muñoz R, Portilla J, Pasquau J, Pérez-Elias MJ, Iribarren JA, Rubio R, Ocampo A, Sánchez-Conde M, Knobel H, Arazo P, Sanz J, López-Aldeguer J, Montes ML, Pulido F; OK04 Study Group. Arribas JR, et al. J Acquir Immune Defic Syndr. 2009 Jun 1;51(2):147-52. doi: 10.1097/QAI.0b013e3181a56de5. J Acquir Immune Defic Syndr. 2009. PMID: 19349870 Clinical Trial.

2

Overcoming resistance: virologic response to a salvage regimen with the combination of ritonavir plus indinavir.

Casado JL, Moreno A, Martí-Belda P, Sabido R, Pinheiro S, Bermudez E, Antela A, Dronda F, Perez-Elías MJ, Moreno S. Casado JL, et al. HIV Clin Trials. 2003 Jan-Feb;4(1):21-8. doi: 10.1310/KDUH-FJC3-NGYH-XPWY. HIV Clin Trials. 2003. PMID: 12577193 Clinical Trial.

3

Severity of the toxicity associated with combinations that include didanosine plus stavudine in HIV-infected experienced patients.

Hernández B, Moreno S, Pérez-Elías MJ, Casado JL, Dronda F, Moreno A, Antela A. Hernández B, et al. J Acquir Immune Defic Syndr. 2006 Dec 15;43(5):556-9. doi: 10.1097/01.qai.0000245881.20768.95. J Acquir Immune Defic Syndr. 2006. PMID: 17057611

4

Lopinavir-ritonavir monotherapy versus lopinavir-ritonavir and two nucleosides for maintenance therapy of HIV.

Pulido F, Arribas JR, Delgado R, Cabrero E, González-García J, Pérez-Elias MJ, Arranz A, Portilla J, Pasquau J, Iribarren JA, Rubio R, Norton M; OK04 Study Group. Pulido F, et al. AIDS. 2008 Jan 11;22(2):F1-9. doi: 10.1097/QAD.0b013e3282f4243b. AIDS. 2008. PMID: 18097218 Clinical Trial.

5

Effect of treatment with efavirenz on neuropsychiatric adverse events of interferon in HIV/HCV-coinfected patients.

Quereda C, Corral I, Moreno A, Pérez-Elías MJ, Casado JL, Dronda F, Rodríguez-Sagrado MA, Hernández B, Moreno S. Quereda C, et al. J Acquir Immune Defic Syndr. 2008 Sep 1;49(1):61-3. doi: 10.1097/QAI.0b013e31817bbeb9. J Acquir Immune Defic Syndr. 2008. PMID: 18667933 Clinical Trial.

6

Risk factors for loss of virological suppression in patients receiving lopinavir/ritonavir monotherapy for maintenance of HIV suppression.

Pulido F, Pérez-Valero I, Delgado R, Arranz A, Pasquau J, Portilla J, Rubio R, González-García J, Miralles P, Pérez-Elías MJ, Ocampo A, Hernando A, Estrada V, Clotet B, Podzamczer D, Arribas JR. Pulido F, et al. Antivir Ther. 2009;14(2):195-201. doi: 10.1177/135965350901400210. Antivir Ther. 2009. PMID: 19430094

7

Safety and pharmacokinetics of lopinavir in HIV/HCV coinfected patients with advanced liver disease.

Casado JL, Del Palacio M, Moya J, Rodriguez JM, Moreno A, Perez-Elías MJ, Belso A, Dronda F, Moreno S. Casado JL, et al. HIV Clin Trials. 2011 Sep-Oct;12(5):235-43. doi: 10.1310/hct1205-235. HIV Clin Trials. 2011. PMID: 22180521 Clinical Trial.

8

Short communication: lamivudine plus a boosted-protease inhibitor as simplification strategy in HIV-infected patients: proof of concept.

Casado JL, de la Calle C, del Palacio M, Perez-Elías MJ, Moreno A, Moreno S. Casado JL, et al. AIDS Res Hum Retroviruses. 2013 Mar;29(3):588-91. doi: 10.1089/aid.2012.0280. Epub 2012 Nov 19. AIDS Res Hum Retroviruses. 2013. PMID: 23163811

9

Lipid-lowering effect and efficacy after switching to etravirine in HIV-infected patients with intolerance to suppressive HAART.

Casado JL, de Los Santos I, Del Palacio M, García-Fraile L, Pérez-Elías MJ, Sanz J, Moreno S. Casado JL, et al. HIV Clin Trials. 2013 Jan-Feb;14(1):1-9. doi: 10.1310/hct1401-1. HIV Clin Trials. 2013. PMID: 23372109

10

Resistance to the most recent protease and non-nucleoside reverse transcriptase inhibitors across HIV-1 non-B subtypes.

Anta L, Blanco JL, Llibre JM, García F, Pérez-Elías MJ, Aguilera A, Pérez-Romero P, Caballero E, Vidal C, Cañizares A, Gutiérrez F, Dalmau D, Iribarren JA, Soriano V, de Mendoza C; Drug Resistance Platform of the Spanish AIDS Research Network. Anta L, et al. J Antimicrob Chemother. 2013 Sep;68(9):1994-2002. doi: 10.1093/jac/dkt146. Epub 2013 Apr 29. J Antimicrob Chemother. 2013. PMID: 23629015

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

255 results

Search Page